319 related articles for article (PubMed ID: 21068248)
41. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication.
Ellis-Connell AL; Iempridee T; Xu I; Mertz JE
J Virol; 2010 Oct; 84(19):10329-43. PubMed ID: 20668090
[TBL] [Abstract][Full Text] [Related]
42. Conserved sequences of BART and BHRF regions encoding viral microRNAs in Epstein-Barr virus-associated lymphoma.
Sunagawa K; Hishima T; Fukumoto H; Hasegawa H; Katano H
BMC Res Notes; 2017 Jul; 10(1):279. PubMed ID: 28705173
[TBL] [Abstract][Full Text] [Related]
43. The Epstein-Barr virus miR-BHRF1-1 targets RNF4 during productive infection to promote the accumulation of SUMO conjugates and the release of infectious virus.
Li J; Callegari S; Masucci MG
PLoS Pathog; 2017 Apr; 13(4):e1006338. PubMed ID: 28414785
[TBL] [Abstract][Full Text] [Related]
44. The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo.
Qiu J; Smith P; Leahy L; Thorley-Lawson DA
PLoS Pathog; 2015 Jan; 11(1):e1004561. PubMed ID: 25590614
[TBL] [Abstract][Full Text] [Related]
45. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
[TBL] [Abstract][Full Text] [Related]
46. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
[TBL] [Abstract][Full Text] [Related]
47. EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells.
Qiu J; Thorley-Lawson DA
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11157-62. PubMed ID: 25012295
[TBL] [Abstract][Full Text] [Related]
48. Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs.
Delecluse S; Yu J; Bernhardt K; Haar J; Poirey R; Tsai MH; Kiblawi R; Kopp-Schneider A; Schnitzler P; Zeier M; Dreger P; Wuchter P; Bulut OC; Behrends U; Delecluse HJ
PLoS One; 2019; 14(9):e0222847. PubMed ID: 31568538
[TBL] [Abstract][Full Text] [Related]
49. The expression of a viral microRNA is regulated by clustering to allow optimal B cell transformation.
Haar J; Contrant M; Bernhardt K; Feederle R; Diederichs S; Pfeffer S; Delecluse HJ
Nucleic Acids Res; 2016 Feb; 44(3):1326-41. PubMed ID: 26635399
[TBL] [Abstract][Full Text] [Related]
50. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
Tierney RJ; Steven N; Young LS; Rickinson AB
J Virol; 1994 Nov; 68(11):7374-85. PubMed ID: 7933121
[TBL] [Abstract][Full Text] [Related]
51. Latency of Epstein-Barr virus is stabilized by antisense-mediated control of the viral immediate-early gene BZLF-1.
Prang N; Wolf H; Schwarzmann F
J Med Virol; 1999 Dec; 59(4):512-9. PubMed ID: 10534735
[TBL] [Abstract][Full Text] [Related]
52. The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis.
Wang YF; He DD; Liang HW; Yang D; Yue H; Zhang XM; Wang R; Li B; Yang HX; Liu Y; Chen Y; Duan YX; Zhang CY; Chen X; Fu J
Clin Exp Immunol; 2017 Jul; 189(1):120-126. PubMed ID: 28253538
[TBL] [Abstract][Full Text] [Related]
53. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
Wang Y; Luo B; Zhao P; Huang BH
Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
[TBL] [Abstract][Full Text] [Related]
54. Epstein-Barr virus-encoded microRNA BART22 serves as novel biomarkers and drives malignant transformation of nasopharyngeal carcinoma.
Zhang T; Chen Z; Deng J; Xu K; Che D; Lin J; Jiang P; Gu X; Xu B
Cell Death Dis; 2022 Jul; 13(7):664. PubMed ID: 35907914
[TBL] [Abstract][Full Text] [Related]
55. A human herpesvirus 6A-encoded microRNA: role in viral lytic replication.
Nukui M; Mori Y; Murphy EA
J Virol; 2015 Mar; 89(5):2615-27. PubMed ID: 25520507
[TBL] [Abstract][Full Text] [Related]
56. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
57. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas.
Luo B; Wang Y; Wang XF; Liang H; Yan LP; Huang BH; Zhao P
World J Gastroenterol; 2005 Feb; 11(5):629-33. PubMed ID: 15655811
[TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus growth/latency III program alters cellular microRNA expression.
Cameron JE; Fewell C; Yin Q; McBride J; Wang X; Lin Z; Flemington EK
Virology; 2008 Dec; 382(2):257-66. PubMed ID: 18950829
[TBL] [Abstract][Full Text] [Related]
59. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection.
Zetterberg H; Stenglein M; Jansson A; Ricksten A; Rymo L
J Gen Virol; 1999 Feb; 80 ( Pt 2)():457-466. PubMed ID: 10073708
[TBL] [Abstract][Full Text] [Related]
60. Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing.
Chen SJ; Chen GH; Chen YH; Liu CY; Chang KP; Chang YS; Chen HC
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
